Vigilare Wealth Management Sangamo Therapeutics, Inc Transaction History

Vigilare Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$7.29 - $10.97 $220,887 - $332,391	-30,300 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$9.01 - $12.01 $144,160 - $192,160	16,000 Added 111.89%	30,300 $273,000
Q2 2021 Jul 16, 2021	SELL	$10.17 - $12.64 $24,408 - $30,336	-2,400 Reduced 14.37%	14,300 $171,000
Q1 2021 Apr 29, 2021	BUY	$10.88 - $17.05 $69,632 - $109,120	6,400 Added 62.14%	16,700 $209,000
Q4 2020 Jan 14, 2021	SELL	$9.23 - $18.18 $104,668 - $206,161	-11,340 Reduced 52.4%	10,300 $161,000
Q3 2020 Oct 15, 2020	SELL	$9.38 - $12.48 $56,373 - $75,004	-6,010 Reduced 21.74%	21,640 $204,000
Q2 2020 Jul 20, 2020	SELL	$6.21 - $11.83 $20,182 - $38,447	-3,250 Reduced 10.52%	27,650 $248,000
Q1 2020 May 04, 2020	BUY	$5.05 - $8.85 $39,390 - $69,030	7,800 Added 33.77%	30,900 $197,000
Q4 2019 Feb 13, 2020	BUY	$8.03 - $11.7 $185,492 - $270,270	23,100 New	23,100 $169,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.